Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of

R B Halberg1, D S Katzung, P D Hoff

  • 1McArdle Laboratory for Cancer Research, Department of Biostatistics, University of Wisconsin, Madison, WI 53706, USA.

Insights

Tumor suppressor gene interactions were studied in mice. p53 deficiency worsened intestinal tumors and desmoid fibromas, but modifiers like Mom1 and drug combinations showed therapeutic potential.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Tumor suppressor genes, such as Adenomatous Polyposis Coli (Apc) and p53, play critical roles in preventing cancer.
  • Interactions between these genes can influence tumor development and progression, but are often confounded by genetic background.
  • Understanding these interactions is crucial for developing targeted cancer therapies.

Purpose of the Study:

  • To investigate the functional interaction between Apc and p53 tumor suppressor genes.
  • To analyze the impact of p53 deficiency on intestinal adenoma and desmoid fibroma development in Apc(Min/+) mice.
  • To evaluate the efficacy of known modifiers (Mom1) and pharmacological agents (piroxicam, difluoromethylornithine) in modulating tumor formation in the absence of p53.

Main Methods:

  • Utilized congenic mouse strains to minimize genetic background variability.
  • Studied Apc(Min/+) mice with and without functional p53.
  • Assessed intestinal adenoma multiplicity and invasiveness, and desmoid fibroma occurrence.
  • Administered the genetic modifier Mom1 and/or pharmacological agents piroxicam and difluoromethylornithine.

Main Results:

  • p53 deficiency significantly enhanced the multiplicity and invasiveness of intestinal adenomas in Apc(Min/+) mice.
  • p53 deficiency also strongly increased the occurrence of desmoid fibromas.
  • The genetic modifier Mom1 and the drug combination of piroxicam and difluoromethylornithine reduced intestinal adenoma multiplicity in p53-deficient mice.
  • Mom1 did not affect desmoid fibroma development, while the drug combination had a moderate effect.

Conclusions:

  • There is a significant synergistic interaction between Apc and p53 in suppressing intestinal tumorigenesis and desmoid fibroma formation.
  • Tissue-specific effects of tumor suppressors and modifiers are evident.
  • Targeting modifiers and utilizing drug combinations may offer therapeutic strategies for cancers with compromised tumor suppressor function.

Related Concept Videos

In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...